The use of zinc stable isotopes in the study of iron-zinc interactions in Chilean women.
The objective of this study was to compare the fractional zinc absorption (FAZ) and the size of the rapidly exchangeable zinc pool (EZP) after three months of iron supplementation in women consuming ferrous sulfate between meals. Twenty-one non-anemic apparently healthy women received on average 55.1 +/- 18.5 mg elemental iron per day as ferrous sulfate, and five received no supplemental iron. Fractional absorption of zinc was determined before and three days after finishing the third month of iron supplementation by using an extrinsic labeling with zinc stable isotopes and a dual isotope enrichment method in urine. EZP was determined from urine enrichment following intravenous administration of 70Zn. Results of selected zinc-related variables in the iron supplemented women were (before vs. after iron supplementation): FAZ with meal 0.22 vs. 0.24, p = .23; FAZ in fasting state 0.58 vs. 0.69, p = .005; EZP 177 mg vs. 160 mg, p = .058; plasma zinc 90.6 vs. 86.1 micrograms/dl, p = .065. The control group remained unchanged. The capacity to absorb zinc was increased three days after terminating a period of iron supplementation as compared with the pre-iron period. This may be attributable to impairment of zinc status by the iron supplements as evidenced by a trend for lower plasma zinc and EZP.
D000293:Adolescent; D000328:Adult; D002677:Chile; D019587:Dietary Supplements; D005260:Female; D005296:Ferrous Compounds / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D019266:Iron, Dietary / Q000008:administration & dosage / Q000494:pharmacology*; D009753:Nutritive Value; D015032:Zinc / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D015033:Zinc Isotopes / Q000652:urine
D005296:Ferrous Compounds; D019266:Iron, Dietary; D015033:Zinc Isotopes; C020748:ferrous sulfate; D015032:Zinc